Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra total assets
Total assets on the balance sheet at the end of each period.
Neutra's total assets was $26.94K at Oct 31, 2023. For fiscal 2023 it was $75.18K, down 42.6% from the year before. Over ten years it grew 26.6% a year on average. The highest annual figure on record is $190.77K in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | $75.18K | -42.6% |
| FY2022 | Jan 31, 2022 | $130.93K | -31.4% |
| FY2021 | Jan 31, 2021 | $190.77K | +4.6% |
| FY2020 | Jan 31, 2020 | $182.33K | +11.5% |
| FY2019 | Jan 31, 2019 | $163.60K | +1227.4% |
| FY2018 | Jan 31, 2018 | $12.33K | – |
| FY2017 | Jan 31, 2017 | $0 | -100.0% |
| FY2016 | Jan 31, 2016 | $284 | -95.7% |
| FY2015 | Jan 31, 2015 | $6.58K | -85.9% |
| FY2014 | Jan 31, 2014 | $46.55K | +555.6% |
| FY2013 | Jan 31, 2013 | $7.10K | -75.4% |
| FY2012 | Jan 31, 2012 | $28.85K | +224.2% |
| FY2011 | Jan 31, 2011 | $8.90K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $26.94K | -72.5% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $36.94K | -74.0% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $54.10K | -63.3% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $75.18K | -42.6% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $97.96K | -45.2% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $141.86K | -18.6% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $147.33K | -29.3% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $130.93K | -31.4% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $178.66K | +7.4% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $174.29K | -6.0% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $208.32K | +55.6% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $190.77K | +4.6% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $166.28K | +959.4% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $185.50K | +181.2% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $133.92K | +26.6% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $182.33K | +11.5% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $15.70K | -85.9% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $65.96K | +115.4% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $105.82K | +13.8% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $163.60K | +1227.4% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $110.93K | +394.1% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $30.63K | +197.6% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $92.98K | +110.3% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $12.33K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $22.45K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $10.29K | +771.5% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $44.20K | +372.8% |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $0 | -100.0% |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | $0 | -100.0% |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | $1.18K | +57.9% |
| Q1 FY2017CQ1 2016 | Apr 30, 2016 | $9.35K | +16.0% |
| Q4 FY2016CQ4 2015 | Jan 31, 2016 | $284 | -95.7% |
| Q3 FY2016CQ3 2015 | Oct 31, 2015 | $620 | -93.2% |
| Q2 FY2016CQ2 2015 | Jul 31, 2015 | $748 | -97.6% |
| Q1 FY2016CQ1 2015 | Apr 30, 2015 | $8.06K | -92.9% |
| Q4 FY2015CQ4 2014 | Jan 31, 2015 | $6.58K | -85.9% |
| Q3 FY2015CQ3 2014 | Oct 31, 2014 | $9.15K | – |
| Q2 FY2015CQ2 2014 | Jul 31, 2014 | $30.94K | – |
| Q1 FY2015CQ1 2014 | Apr 30, 2014 | $114.10K | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | $46.55K | – |
See a number that looks wrong?